Matthew Frohn is a Managing Partner and Co-Founder at Longwall Ventures, which he founded with David Denny and Michael Penington. He has a D.Phil in Biochemistry from the University of Oxford and venture investing experience since 1999, with prior experience in clinical pathology, virology, and drug development.
Access investment thesis, focus areas, bio, and contact details for Matthew Frohn and 22,000+ other VC professionals.